Safar Partners
  • Approach
  • Mission
  • Team
  • Portfolio
  • News
  • Contact
Select Page

Amy Ripka, CEO of Lucy Therapeutics, was recently interviewed for American Chemical Society’s Industry Matters Newsletter

Feb 15, 2021 | All Portfolio Companies, Life Sciences

ACS – “Amy Ripka is CEO of Lucy Therapeutics, a Boston-based, mitochondrial platform biotech, revolutionizing treatments for rare and neurological diseases. Previous to her role at LucyTx, she served on the executive leadership teams at SAI Life Sciences...

Sophie Vandebroek joins Safar Partner’s Scientific Advisory Board

Feb 11, 2021 | Safar Organization

We are very excited to have Sophie join Safar’s Scientific Advisory Board! We are confident Sophie will be a strong asset for our growing portfolio of cleantech and material science, as well as AI and IT companies.  Sophie Vandebroek is founder and owner of Strategic...

Archives

  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • October 2022
  • August 2022
  • June 2022
  • April 2022
  • February 2022
  • January 2022
  • December 2021
  • September 2021
  • August 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019

Categories

  • AI / IT / Robotics
  • All Portfolio Companies
  • Clean Tech / Advanced Materials
  • Life Sciences
  • Safar Organization
  • Approach
  • Mission
  • Team
  • Portfolio
  • News
  • Contact
  • Terms of Use
  • Privacy Policy